Exhaled nitric oxide is increased in active fibrosing alveolitis.

作者: Paolo Paredi , S.A. Kharitonov , S. Loukides , P. Pantelidis , R. M. du Bois

DOI: 10.1378/CHEST.115.5.1352

关键词:

摘要: Study objectives Interstitial inflammation is a major aggravating factor in fibrosing lung disease associated with scleroderma (FASSc) and cryptogenic alveolitis (CFA). Exhaled nitric oxide (NO) production increased asthma bronchiectasis reflects the degree of inflammation. We investigated whether measuring levels exhaled NO valuable assessing activity patients CFA FASSc. Measurements results were measured 11 (mean age ± SEM, 58 12 years old; 5 male) 17 FASSc age, 48 9 male), they compared to BAL cell counts function. Patients had elevated (11.2 1.0 parts per billion [ppb] 9.8 ppb, respectively; p > 0.05), whereas group 13 nonsmoking normal subjects, not (6.9 0.5 ppb; 14%, neutrophils 4%, or eosinophils 3%) significantly higher (13.2 1.8 ppb), neutrophil (16.5 4.0%) lymphocyte (26.8 3.4%) than did who inactive (6.7 1.2 1.3 1.0% 7.5 1.3%, Conclusions conclude that may be useful addition monitoring.

参考文章(28)
C. Nathan, Q.W. Xie, Regulation of biosynthesis of nitric oxide. Journal of Biological Chemistry. ,vol. 269, pp. 13725- 13728 ,(1994) , 10.1016/S0021-9258(17)36703-0
S. Kharitonov, K. Alving, P.J. Barnes, Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. European Respiratory Journal. ,vol. 10, pp. 1683- 1693 ,(1997) , 10.1183/09031936.97.10071683
Elizabeth J. Kovacs, Luisa A. Dipietro, Fibrogenic cytokines and connective tissue production. The FASEB Journal. ,vol. 8, pp. 854- 861 ,(1994) , 10.1096/FASEBJ.8.11.7520879
J. S. Beckman, W. H. Koppenol, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. American Journal of Physiology-cell Physiology. ,vol. 271, ,(1996) , 10.1152/AJPCELL.1996.271.5.C1424
Sergei A Kharitonov, Athol U Wells, Brian J O'Connor, Peter J Cole, David M Hansell, RB Logan-Sinclair, Peter J Barnes, Elevated levels of exhaled nitric oxide in bronchiectasis. American Journal of Respiratory and Critical Care Medicine. ,vol. 151, pp. 1889- 1893 ,(1995) , 10.1164/AJRCCM.151.6.7767536
D. Wink, K. Kasprzak, C. Maragos, R. Elespuru, M Misra, T. Dunams, T. Cebula, W. Koch, A. Andrews, J. Allen, al. et, DNA deaminating ability and genotoxicity of nitric oxide and its progenitors Science. ,vol. 254, pp. 1001- 1003 ,(1991) , 10.1126/SCIENCE.1948068
J Behr, C Vogelmeier, T Beinert, M Meurer, F Krombach, G König, G Fruhmann, Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. American Journal of Respiratory and Critical Care Medicine. ,vol. 154, pp. 400- 406 ,(1996) , 10.1164/AJRCCM.154.2.8756813
János Strausz, Joachim Müller-Quernheim, Harald Steppling, Rudolf Ferlinz, Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. The American review of respiratory disease. ,vol. 141, pp. 124- 128 ,(1990) , 10.1164/AJRCCM/141.1.124
J R Mathieson, J R Mayo, C A Staples, N L Müller, Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology. ,vol. 171, pp. 111- 116 ,(1989) , 10.1148/RADIOLOGY.171.1.2928513
S.A. Kharitonov, D. Yates, R.A. Robbins, P.J. Barnes, R. Logan-Sinclair, E.A. Shinebourne, Increased nitric oxide in exhaled air of asthmatic patients The Lancet. ,vol. 343, pp. 133- 135 ,(1994) , 10.1016/S0140-6736(94)90931-8